LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 868 | 1365 | 3556 | 0.3852 | 0.2472 |
MDA-MB-231 | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 868 | 1340 | 3556 | 0.3772 | 0.2381 |
MDA-MB-231 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 868 | 1260 | 3556 | 0.3550 | 0.2013 |
MDA-MB-231 | AZD8055 | 10 | uM | LJP6 | 72 | hr | 868 | 980 | 3556 | 0.2765 | 0.0615 |
MDA-MB-231 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 868 | 3447 | 3556 | 0.9711 | 0.9714 |
MDA-MB-231 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 868 | 2798 | 3556 | 0.7880 | 0.7786 |
MDA-MB-231 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 868 | 2860 | 3556 | 0.8057 | 0.7984 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 868 | 2640 | 3556 | 0.7424 | 0.7275 |
MDA-MB-231 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 868 | 2760 | 3556 | 0.7769 | 0.7667 |
MDA-MB-231 | Sorafenib | 10 | uM | LJP6 | 72 | hr | 868 | 2448 | 3556 | 0.6884 | 0.6645 |
MDA-MB-231 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 868 | 3815 | 3410 | 1.1190 | 1.1172 |
MDA-MB-231 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3685 | 3410 | 1.0811 | 1.0807 |
MDA-MB-231 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 868 | 3509 | 3410 | 1.0290 | 1.0292 |
MDA-MB-231 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 868 | 3252 | 3410 | 0.9536 | 0.9517 |
MDA-MB-231 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 868 | 3398 | 3410 | 0.9960 | 0.9952 |
MDA-MB-231 | CP466722 | 10 | uM | LJP5 | 72 | hr | 868 | 1730 | 3410 | 0.5070 | 0.4168 |
MDA-MB-231 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 868 | 2656 | 3410 | 0.7801 | 0.7628 |
MDA-MB-231 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 868 | 2625 | 3410 | 0.7714 | 0.7524 |
MDA-MB-231 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 868 | 2643 | 3410 | 0.7754 | 0.7578 |
MDA-MB-231 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 868 | 2825 | 3410 | 0.8294 | 0.8192 |
MDA-MB-231 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 868 | 2362 | 3410 | 0.6926 | 0.6567 |
MDA-MB-231 | CP724714 | 10 | uM | LJP5 | 72 | hr | 868 | 2329 | 3410 | 0.6843 | 0.6492 |
MDA-MB-231 | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 868 | 1237 | 3556 | 0.3481 | 0.1902 |
MDA-MB-231 | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 868 | 635 | 3556 | 0.1789 | -0.1423 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 868 | 611 | 3556 | 0.1720 | -0.1586 |